SALIX PHARMACEUTICALS LTD DEL
SLXP
SLXP was delisted on the 31st of March, 2015.
0 hedge funds and large institutions have $0 invested in SALIX PHARMACEUTICALS LTD DEL in 2015 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $52K → $0 (-$52K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MMG
Monetary Management Group
St Louis,
Missouri
|
-$52K |
SLXP Hedge Fund Activity: Q3 2015 in Review
0 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q3 2015, worth a combined $0 — down 100% from $52K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SLXP and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Monetary Management Group, exiting entirely with an estimated $52K sold.
- 0 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q3 2015, down from 1 in Q2 2015.
- Funds reported $0 of SALIX PHARMACEUTICALS LTD DEL stock for Q3 2015, down 100% quarter-over-quarter.
- 0 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q3 2015 and 1 closed out, a net change of -1 holder.
- The largest SALIX PHARMACEUTICALS LTD DEL seller in Q3 2015 was Monetary Management Group, an estimated $52K sold.
Based on aggregated 13F filings for Q3 2015.